Melanoma: open trials in Russia

• NCT03340506

  Dabrafenib and/or Trametinib Rollover Study

  Trial Treatment · Phase 4 · Novartis Pharmaceuticals

  Moscow

  Registry updated 2026-11-03

• NCT04752826

  BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)

  Trial Treatment · Phase 1/2 · BioInvent International AB

  Byudzhetnoye Uchrezhdeniye Zdravookhraneniya Omskoy Oblasti - Klinicheskiy Onkologicheskiy Dispanser, Omsk · National Medical Research Center VA Almazov, Saint Petersburg · N.N. Petrov National Medical Research Center of Oncology, Saint Petersburg

  Registry updated 2026-09-18

• NCT07130032

  Efficacy And Safety Of Anti-PD-1/PD-L1 Antibodies In Combination With Bevacizumab And Metronomic Cyclophosphamide In Patients With Non-Small Cell Lung Cancer And Cutaneous Melanoma Previously Treated With Immune Checkpoint Blockade

  Trial Treatment · Phase 2 · EuroCityClinic LLC

  EuroCityClinic LLC, Saint Petersburg

  Registry updated 2025-08-19

• NCT05539677

  Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research

  Research · N.N. Petrov National Medical Research Center of Oncology

  N.N. Petrov NMRC of Oncology, Oncoimmunology dep., Saint Petersburg

  Registry updated 2024-05-06

All Melanoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error